Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Short-term Investments (2019 - 2025)

Korro Bio (KRRO) has disclosed Short-term Investments for 6 consecutive years, with $68.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-term Investments rose 3764.48% year-over-year to $68.3 million, compared with a TTM value of $68.3 million through Sep 2025, up 3764.48%, and an annual FY2024 reading of $70.5 million, up 1877.32% over the prior year.
  • Short-term Investments was $68.3 million for Q3 2025 at Korro Bio, up from $62.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $70.5 million in Q4 2024 and bottomed at $1.8 million in Q3 2024.
  • Average Short-term Investments over 5 years is $32.3 million, with a median of $29.8 million recorded in 2021.
  • The sharpest move saw Short-term Investments tumbled 81.16% in 2023, then surged 3764.48% in 2025.
  • Year by year, Short-term Investments stood at $51.1 million in 2021, then plummeted by 62.96% to $18.9 million in 2022, then crashed by 81.16% to $3.6 million in 2023, then surged by 1877.32% to $70.5 million in 2024, then fell by 3.02% to $68.3 million in 2025.
  • Business Quant data shows Short-term Investments for KRRO at $68.3 million in Q3 2025, $62.8 million in Q2 2025, and $70.5 million in Q4 2024.